US 10676740
Modified iRNA agents
granted A61KA61K47/55A61K47/554
Quick answer
US patent 10676740 (Modified iRNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K47/55, A61K47/554